NI
KYMR icon

Nextech Invest’s Kymera Therapeutics KYMR Stock Holding History

Nextech Invest’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32M Hold
278,896
– – 1.52% 7
2026
Q1 		$23.2M Hold
278,896
– – 1.63% 8
2025
Q4 		$21.7M Sell
278,896
-62,013
-18% -$4.19M 2.1% 8
2025
Q3 		$19.3M Hold
340,909
– – 2.94% 6
2025
Q2 		$14.9M Buy
+340,909
New +$11.7M 2.82% 5

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Nextech Invest's KYMR Position: Q2 2026 in Review

Nextech Invest held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 278,896 shares worth $32M. The position accounts for 1.52% of the portfolio, ranked #7.

Nextech Invest first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Nextech Invest held 278,896 shares of Kymera Therapeutics worth $32M as of Q2 2026.
  • Nextech Invest left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up 1.52% of Nextech Invest's portfolio in Q2 2026, its #7 holding.
  • Nextech Invest first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Nextech Invest's 13F filing for Q2 2026, filed 14 Aug 2026.